Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Data

v3.22.4
Selected Balance Sheet Data
6 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Selected Balance Sheet Data

Note 3. Selected Balance Sheet Data:

Inventories:

Inventories consist of (in thousands):

    

December 31, 

June 30, 

    

2022

    

2022

Raw materials

$

84,757

$

79,291

Finished goods(1)

 

80,548

 

66,943

Inventories, net

$

165,305

$

146,234

(1) Finished goods inventory of $5,072 and $5,111 included within other long-term assets in the respective December 31, 2022 and June 30, 2022, consolidated balance sheet. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.

Property and Equipment:

Property and equipment consist of (in thousands):

    

December 31, 

June 30, 

    

2022

    

2022

Land

$

9,079

$

8,572

Buildings and improvements

 

242,340

 

229,551

Machinery and equipment

182,306

174,813

Construction in progress

 

13,469

 

21,729

Property and equipment, cost

 

447,194

 

434,665

Accumulated depreciation and amortization

 

(223,343)

 

(211,423)

Property and equipment, net

$

223,851

$

223,242

Intangible Assets:

Intangible assets consist of (in thousands):

December 31, 

June 30, 

2022

2022

Developed technology

$

615,301

$

542,038

Trade names

 

146,618

 

146,457

Customer relationships

 

224,212

 

225,882

Patents

 

3,514

 

3,313

Other intangibles

 

6,894

 

6,306

Definite-lived intangible assets

 

996,539

 

923,996

Accumulated amortization

 

(451,592)

 

(415,174)

Definite-lived intangibles assets, net

 

544,947

 

508,822

In process research and development

 

22,700

 

22,700

Total intangible assets, net

$

567,647

$

531,522

Changes to the carrying amount of net intangible assets for the period ended December 31, 2022 consist of (in thousands):

Beginning balance

$

531,522

Acquisitions

 

75,600

Other additions

 

713

Amortization expense

 

(38,861)

Currency translation

(1,327)

Ending balance

$

567,647

The estimated future amortization expense for intangible assets as of December 31, 2022 is as follows (in thousands):

Remainder 2023

    

$

38,462

2024

 

74,764

2025

 

71,341

2026

 

67,478

2027

 

57,326

Thereafter

 

235,576

Total

$

544,947

Goodwill:

Changes to the carrying amount of goodwill for the period ended December 31, 2022 consist of (in thousands):

    

    

Diagnostics and

    

Protein Sciences

 Genomics

Total

June 30, 2022

$

376,493

$

445,608

$

822,101

Acquisitions

 

51,051

-

51,051

Currency translation

 

(3,623)

60

(3,563)

December 31, 2022

$

423,921

$

445,668

$

869,589

We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a quantitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2022. No indicators of impairment were identified as part of our assessment.